Compare TLRY & CHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLRY | CHY |
|---|---|---|
| Founded | N/A | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 688.9M | 896.9M |
| IPO Year | 2018 | N/A |
| Metric | TLRY | CHY |
|---|---|---|
| Price | $5.58 | $12.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $72.33 | N/A |
| AVG Volume (30 Days) | ★ 6.8M | 205.0K |
| Earning Date | 04-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.11% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.79 | N/A |
| Revenue Next Year | $19.98 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $10.20 |
| 52 Week High | $15.70 | $12.91 |
| Indicator | TLRY | CHY |
|---|---|---|
| Relative Strength Index (RSI) | 35.19 | 70.74 |
| Support Level | $1.00 | $11.19 |
| Resistance Level | $7.01 | N/A |
| Average True Range (ATR) | 0.53 | 0.17 |
| MACD | -0.12 | 0.05 |
| Stochastic Oscillator | 2.72 | 91.46 |
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high-yield securities.